about
The role of pesticide exposure in the genesis of Parkinson's disease: Epidemiological studies and experimental dataPromotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitorsNeurobehavioral and neurodevelopmental effects of pesticide exposuresFood contamination control in European new Member States and associated candidate countries: data collected within the SAFEFOODNET project.Experimental and clinical toxicology of anticholinesterase agents.Integration of biological monitoring, environmental monitoring and computational modelling into the interpretation of pesticide exposure data: introduction to a proposed approach.The ethics of human volunteer studies involving experimental exposure to pesticides: unanswered dilemmasOrganophosphate-induced delayed polyneuropathy.Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water.Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.Cumulative risk assessment of pesticide residues in food.Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson's disease.A 21st century roadmap for human health risk assessment.Risk assessment in the 21st century: roadmap and matrix.Stem cell-derived systems in toxicology assessment.Hexavalent and trivalent chromium in leather: What should be done?Exposure assessment for chemical and physical agents.Blood lead levels following consumption of game meat in Italy.A framework for cumulative risk assessment in the 21st century.Problem formulation for risk assessment of combined exposures to chemicals and other stressors in humans.Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.The search for the physiological functions of NTE; is NTE a receptor?In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2-dichlorovinyl phosphate.Testing a cumulative and aggregate exposure model using biomonitoring studies and dietary records for Italian vineyard spray operators.Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers.Organophosphate polyneuropathy in chicks.Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy.The relationship between isofenphos cholinergic toxicity and the development of polyneuropathy in hens and humans.Progressive deficits in retrograde axon transport precede degeneration of motor axons in acrylamide neuropathy.Slow release of two antibiotics of veterinary interest from PVA hydrogels.Neurobehavioural effects of pesticides with special focus on organophosphorus compounds: which is the real size of the problem?Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society.Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens.The use of in vitro testing to refine cumulative assessment groups of pesticides: The example of teratogenic conazoles.The ACROPOLIS project: Its aims, achievements, and way forward.Repeated low doses of O-(2-chloro-2,3,3 trifluorocyclobutyl) O-ethyl S-propyl phosphorothioate (KBR-2822) do not cause neuropathy in hens.Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.Chlorpyrifos-induced delayed polyneuropathy.Effects of mixtures of azole fungicides in postimplantation rat whole-embryo cultures.
P50
Q22251422-C4EDB9E9-5F1B-47A2-A502-3C222D9917B2Q28369678-BD325E18-BD26-4C7D-9CD8-1CCBD60D1DBDQ28385370-8745F68C-711D-48BB-8483-F0D6A2B9148AQ33430057-B2533CB3-EE52-4CCC-BBF8-E920B64D91E2Q33534057-12DD3B75-9414-43CF-8DB0-2B1C59D5F7C8Q34014202-10C81528-ACDC-44B6-A542-614EA197FC3CQ34097909-AC0BF544-E033-4305-BCE9-8A390E0823E1Q34436723-79B8CC29-70FE-4C90-8491-D8DA50C6EAD7Q36519131-8FD33D9F-1C54-4D25-9A5C-83B0B7EC5021Q36934924-1BC564E5-228A-460D-8463-5449727F4D17Q37201801-9A4C14A2-6AC9-4433-A9D9-E80B9AA1730FQ37852836-C3B61A85-0FC8-49FA-9705-AE9B948B59EAQ38234791-FD64056E-2ED5-42AF-A757-C68AF72642C4Q38234793-703400EC-B11B-4F4D-9336-E47BE4932336Q38353008-88B8C67F-681A-4E6E-AF4D-1C7E1981A172Q38585134-10214858-91F3-486C-9A8C-AFA19E044AEAQ38632135-C3021112-01BB-4D3E-B755-9D1EEAFE1E96Q38966019-E9436345-4C25-4878-BA0C-2F602693B9F2Q39338793-7383D82E-5E43-42B9-B2C6-E3B8168022ABQ39339057-4A7598AF-36ED-49C5-83C7-97E163535D36Q40767381-66F400C9-BF75-40C8-938A-6BC7DC6D77F9Q40856532-41D2B9CC-5B1A-4524-A8F3-2738510F4CC1Q41287738-7B345B2B-B2CD-4131-B73D-A11013799623Q41647069-D25223EA-79C0-450E-B387-2C5DD870945DQ42277590-145B25A4-69FD-40D5-A6CC-7A31AD256F71Q42288705-3F97176C-52B8-426A-ADE5-26CB576369F2Q43673051-20FB489D-284C-4773-9474-A98FF16C143FQ44055552-81DC87B0-D599-49B0-BBE8-8468D11E0B11Q44680684-A8E6B964-547A-495E-83F9-B90896841A02Q44748128-FD02007D-BA03-4E99-A89E-9A298ADB0019Q45759007-6D983A53-18CA-4B07-8D1A-B0981E3C739BQ46053835-E581E5BE-D6F8-4602-92EB-D229E2624CDDQ46471070-37044099-313E-4A84-9768-B4A98723DCF6Q46769004-B0AD2E2D-0D32-42BB-84E7-0AB96584B8BFQ46807187-8477760D-E2D3-4189-814D-B3BA9EB6E874Q48043580-75957A01-42BE-44EE-B2C7-006AC15EA86DQ48545885-DBD6A74A-7160-4D76-BE14-E1103FA1AC1BQ48625072-62F212F2-63BE-40FE-8EE6-10017DB718F8Q48821793-3CAF5DAC-0EE8-4D45-89B2-F4A0EB34D748Q51236752-2A6D1E94-68C9-44DB-9BFE-2A76C9516828
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angelo Moretto
@ast
Angelo Moretto
@en
Angelo Moretto
@es
Angelo Moretto
@nl
type
label
Angelo Moretto
@ast
Angelo Moretto
@en
Angelo Moretto
@es
Angelo Moretto
@nl
prefLabel
Angelo Moretto
@ast
Angelo Moretto
@en
Angelo Moretto
@es
Angelo Moretto
@nl
P1053
F-1581-2017
P106
P1153
56212822600
P21
P31
P3829
P496
0000-0003-4386-5736